• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性环氧化物水解酶的强效尿素和氨基甲酸酯抑制剂。

Potent urea and carbamate inhibitors of soluble epoxide hydrolases.

作者信息

Morisseau C, Goodrow M H, Dowdy D, Zheng J, Greene J F, Sanborn J R, Hammock B D

机构信息

Department of Entomology, University of California, Davis, CA 95616, USA.

出版信息

Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8849-54. doi: 10.1073/pnas.96.16.8849.

DOI:10.1073/pnas.96.16.8849
PMID:10430859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC17696/
Abstract

The soluble epoxide hydrolase (sEH) plays a significant role in the biosynthesis of inflammation mediators as well as xenobiotic transformations. Herein, we report the discovery of substituted ureas and carbamates as potent inhibitors of sEH. Some of these selective, competitive tight-binding inhibitors with nanomolar K(i) values interacted stoichiometrically with the homogenous recombinant murine and human sEHs. These inhibitors enhance cytotoxicity of trans-stilbene oxide, which is active as the epoxide, but reduce cytotoxicity of leukotoxin, which is activated by epoxide hydrolase to its toxic diol. They also reduce toxicity of leukotoxin in vivo in mice and prevent symptoms suggestive of acute respiratory distress syndrome. These potent inhibitors may be valuable tools for testing hypotheses of involvement of diol and epoxide lipids in chemical mediation in vitro or in vivo systems.

摘要

可溶性环氧化物水解酶(sEH)在炎症介质的生物合成以及外源性物质的转化过程中发挥着重要作用。在此,我们报告了取代脲和氨基甲酸酯作为sEH强效抑制剂的发现。其中一些具有纳摩尔K(i)值的选择性、竞争性紧密结合抑制剂与同源重组小鼠和人sEH进行了化学计量相互作用。这些抑制剂增强了反式氧化芪(作为环氧化物具有活性)的细胞毒性,但降低了白细胞毒素(通过环氧化物水解酶激活为其有毒二醇)的细胞毒性。它们还降低了小鼠体内白细胞毒素的毒性,并预防了提示急性呼吸窘迫综合征的症状。这些强效抑制剂可能是用于测试二醇和环氧化物脂质在体外或体内系统化学介导中所涉及假设的有价值工具。

相似文献

1
Potent urea and carbamate inhibitors of soluble epoxide hydrolases.可溶性环氧化物水解酶的强效尿素和氨基甲酸酯抑制剂。
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8849-54. doi: 10.1073/pnas.96.16.8849.
2
Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).新型 1-芳基-3-(1-酰基哌啶-4-基)脲作为人可溶性环氧化物水解酶抑制剂 (sEHIs) 的药效团建模和基于原子的 3D-QSAR 研究。
Med Chem. 2011 Nov;7(6):581-92. doi: 10.2174/157340611797928479.
3
Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.不对称 N,N'-二芳基脲类可溶性环氧化物水解酶抑制剂的次要和 tertiary 药效团的探索。
Bioorg Med Chem Lett. 2010 May 1;20(9):2740-4. doi: 10.1016/j.bmcl.2010.03.074. Epub 2010 Mar 19.
4
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.基于尿素的可溶性环氧化物水解酶抑制剂的结构优化
Biochem Pharmacol. 2002 May 1;63(9):1599-608. doi: 10.1016/s0006-2952(02)00952-8.
5
Identification of potent inhibitors of the chicken soluble epoxide hydrolase.鸡可溶性环氧化物水解酶强效抑制剂的鉴定
Bioorg Med Chem Lett. 2015 Jan 15;25(2):276-9. doi: 10.1016/j.bmcl.2014.11.053. Epub 2014 Nov 26.
6
Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.探究可溶性环氧化物水解酶抑制剂疏水区部分的大小。
Bioorg Med Chem. 2019 Oct 15;27(20):115078. doi: 10.1016/j.bmc.2019.115078. Epub 2019 Aug 26.
7
Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.可溶性环氧化物水解酶构象受限抑制剂的合成与构效关系
Bioorg Med Chem Lett. 2006 Oct 1;16(19):5212-6. doi: 10.1016/j.bmcl.2006.07.009. Epub 2006 Jul 25.
8
Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.作为具有更高水溶性的可溶性环氧化物水解酶强效抑制剂的1,3-二取代脲的设计、合成及生物活性
J Med Chem. 2004 Apr 8;47(8):2110-22. doi: 10.1021/jm030514j.
9
Inhibition of microsomal epoxide hydrolases by ureas, amides, and amines.脲、酰胺和胺对微粒体环氧化物水解酶的抑制作用。
Chem Res Toxicol. 2001 Apr;14(4):409-15. doi: 10.1021/tx0001732.
10
Peptidyl-urea based inhibitors of soluble epoxide hydrolases.基于肽基脲的可溶性环氧化物水解酶抑制剂。
Bioorg Med Chem Lett. 2006 Oct 15;16(20):5439-44. doi: 10.1016/j.bmcl.2006.07.073.

引用本文的文献

1
The impact of the soluble epoxide hydrolase cascade on periodontal tissues.可溶性环氧化物水解酶级联反应对牙周组织的影响。
Front Dent Med. 2023 Feb 1;4:1129371. doi: 10.3389/fdmed.2023.1129371. eCollection 2023.
2
Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.评估磺酰脲衍生物作为可溶性环氧化物水解酶 (sEH) 抑制剂的治疗潜力。
Molecules. 2024 Jun 26;29(13):3036. doi: 10.3390/molecules29133036.
3
Inhibition of soluble epoxide hydrolase by natural isothiocyanates.天然异硫氰酸酯对可溶性环氧化物水解酶的抑制作用。
Biochem Biophys Res Commun. 2024 Sep 17;725:150261. doi: 10.1016/j.bbrc.2024.150261. Epub 2024 Jun 12.
4
Santacruzamate A Alleviates Pain and Pain-Related Adverse Emotions through the Inhibition of Microglial Activation in the Anterior Cingulate Cortex.圣塔克鲁扎胺A通过抑制前扣带回皮质中的小胶质细胞激活来减轻疼痛及与疼痛相关的不良情绪。
ACS Pharmacol Transl Sci. 2024 Feb 16;7(4):1002-1012. doi: 10.1021/acsptsci.3c00282. eCollection 2024 Apr 12.
5
Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.发现 sEH 抑制剂 Epoxykynin 作为一种有效的犬尿氨酸途径调节剂。
J Med Chem. 2024 Mar 28;67(6):4691-4706. doi: 10.1021/acs.jmedchem.3c02245. Epub 2024 Mar 12.
6
Screening and Biological Evaluation of Soluble Epoxide Hydrolase Inhibitors: Assessing the Role of Hydrophobicity in the Pharmacophore-Guided Search of Novel Hits.可溶性环氧化物水解酶抑制剂的筛选和生物学评价:评估疏水性在基于药效团的新型命中物搜索中的作用。
J Chem Inf Model. 2023 May 22;63(10):3209-3225. doi: 10.1021/acs.jcim.3c00301. Epub 2023 May 4.
7
PROTAC-Mediated Selective Degradation of Cytosolic Soluble Epoxide Hydrolase Enhances ER Stress Reduction.PROTAC 介导的细胞质可溶性环氧化物水解酶的选择性降解增强内质网应激的减轻。
ACS Chem Biol. 2023 Apr 21;18(4):884-896. doi: 10.1021/acschembio.3c00017. Epub 2023 Mar 22.
8
Immune Function of Endothelial Cells: Evolutionary Aspects, Molecular Biology and Role in Atherogenesis.内皮细胞的免疫功能:进化方面、分子生物学及在动脉粥样硬化形成中的作用。
Int J Mol Sci. 2022 Aug 29;23(17):9770. doi: 10.3390/ijms23179770.
9
Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation.基于 3D 结构的药效团模型驱动研究对可溶性环氧化物水解酶(sEH)进行喹唑啉二酮类化合物的重新定位。
Molecules. 2022 Jun 16;27(12):3866. doi: 10.3390/molecules27123866.
10
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID-19.通过可溶性环氧化物水解酶抑制剂激活内源性解决途径来管理 COVID-19。
Arch Pharm (Weinheim). 2022 Mar;355(3):e2100367. doi: 10.1002/ardp.202100367. Epub 2021 Nov 21.

本文引用的文献

1
Kinetic and chemical mechanism of epoxide hydrolase.环氧水解酶的动力学和化学机制。
Drug Metab Rev. 1999 Feb;31(1):71-86. doi: 10.1081/dmr-100101908.
2
Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.环氧二十碳三烯酸和二羟基二十碳三烯酸是犬冠状动脉微循环中的强效血管舒张剂。
Circ Res. 1998 Nov 2;83(9):932-9. doi: 10.1161/01.res.83.9.932.
3
Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives.查尔酮氧化物衍生物对哺乳动物可溶性环氧化物水解酶的抑制机制。
Arch Biochem Biophys. 1998 Aug 15;356(2):214-28. doi: 10.1006/abbi.1998.0756.
4
Expression and characterization of the recombinant juvenile hormone epoxide hydrolase (JHEH) from Manduca sexta.烟草天蛾重组保幼激素环氧水解酶(JHEH)的表达与特性分析
Insect Biochem Mol Biol. 1998 May-Jun;28(5-6):409-19. doi: 10.1016/s0965-1748(98)00014-9.
5
The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics.人类谷胱甘肽转移酶和环氧化物水解酶在异生素代谢中的作用。
Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):791-9. doi: 10.1289/ehp.105-1470052.
6
Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase.白细胞毒素通过环氧水解酶生物激活为其毒性二醇。
Nat Med. 1997 May;3(5):562-6. doi: 10.1038/nm0597-562.
7
Lipid oxidation products in ischemic porcine heart tissue.缺血猪心脏组织中的脂质氧化产物。
Chem Phys Lipids. 1996 Jul 30;82(1):39-51. doi: 10.1016/0009-3084(96)02557-1.
8
Improved radiolabeled substrates for soluble epoxide hydrolase.用于可溶性环氧化物水解酶的改良放射性标记底物。
Anal Biochem. 1995 Oct 10;231(1):188-200. doi: 10.1006/abio.1995.1520.
9
Development of an in situ toxicity assay system using recombinant baculoviruses.利用重组杆状病毒开发原位毒性测定系统。
Biochem Pharmacol. 1996 Feb 23;51(4):503-15. doi: 10.1016/0006-2952(95)02227-9.
10
Endothelin-1 potentiates leukotoxin-induced edematous lung injury.内皮素-1增强白细胞毒素诱导的肺水肿性肺损伤。
J Appl Physiol (1985). 1995 Oct;79(4):1106-11. doi: 10.1152/jappl.1995.79.4.1106.